Trial intelligence / Profile preview

Trivalent influenza vaccination methods in maintenance hemodialysis patients

IRCT2015101724575N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Feb 2016
Countries
1
01

Overview

Phase 3 trial of trivalent influenza vaccine in influenza (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Post-vaccination immunogenicity. Started Feb 2016; status: completed.

02

Drugs

trivalent influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on IRCT2015101724575N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015101724575N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call